12:40~13:10 |
The latest options for treatment of type 2 diabetes patients 홍은경 (한림의대) |
12:40~13:10 |
PCSK9 inhibitor : New hope for FH treatment 최성희 (서울의대) |
07:30-08:10 |
Treatment of dyslipidemia in elderly patients 김소헌 (인제의대) |
07:30-08:10 |
Statins in cardiometabolic disease: What makes pitavastatin different? 정인경 (경희의대) |
12:10~12:40 |
New paradigm of glycemic variability: EVERGREEN study 김미경 (인제의대) |
12:10~12:40 |
Rediscovery of pioglitazone: From β-cell to CV outcome 김성래 (가톨릭의대) |